- Tytuł:
- Phase I active immunotherapy with combination of two chimeric, human epidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and/or recurrent solid tumors.
- Autorzy:
- Źródło:
- Journal of Clinical Oncology; 11/1/2009, Vol. 27 Issue 31, p5270-5277, 8p
- Czasopismo naukowe